1. Home
  2. GLBE vs BLCO Comparison

GLBE vs BLCO Comparison

Compare GLBE & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global-E Online Ltd.

GLBE

Global-E Online Ltd.

HOLD

Current Price

$38.70

Market Cap

6.9B

Sector

Technology

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$17.01

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLBE
BLCO
Founded
2013
1853
Country
Israel
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Ophthalmic Goods
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
6.0B
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
GLBE
BLCO
Price
$38.70
$17.01
Analyst Decision
Buy
Hold
Analyst Count
13
14
Target Price
$49.46
$17.31
AVG Volume (30 Days)
1.7M
408.9K
Earning Date
11-19-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.04
N/A
Revenue
$888,450,000.00
$4,976,000,000.00
Revenue This Year
$29.10
$8.08
Revenue Next Year
$24.09
$5.77
P/E Ratio
$1,030.49
N/A
Revenue Growth
31.57
6.23
52 Week Low
$26.64
$10.45
52 Week High
$63.69
$18.99

Technical Indicators

Market Signals
Indicator
GLBE
BLCO
Relative Strength Index (RSI) 51.51 61.24
Support Level $37.85 $16.39
Resistance Level $40.62 $17.41
Average True Range (ATR) 1.36 0.44
MACD -0.16 0.05
Stochastic Oscillator 21.92 69.20

Price Performance

Historical Comparison
GLBE
BLCO

About GLBE Global-E Online Ltd.

Global E Online Ltd provides e-commerce solutions. The company offers a platform to enable and accelerate direct-to-consumer cross-border e-commerce. The platform was purpose-built for international shoppers to buy seamlessly online and for merchants to sell from and anywhere in the world. The company localizes the shopper experience to make international transactions as seamless as domestic ones. The platform increases the conversion of international traffic into sales by removing much of the complexity associated with international e-commerce. The company derives maximum revenue from the United States.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: